Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Psoriasis × sodium luminolate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Psoriasis 1 Plaque, Amyloid 1 Lymphoma, Follicular 1 Bronchiolitis Obliterans Syndrome 1

Interventions

tofacitinib 7 Etanercept 4 deucravacitinib 2 Methotrexate 2 Adalimumab 2 sotrastaurin 1 sodium luminolate 1 secukinumab 1 ixekizumab 1 calcipotriene 1 baricitinib 1 apremilast 1 abrocitinib 1 Anti-Infective Agents, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02908347 2019-01-23

Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients

MetrioPharm AG

Phase 2 Completed

46 enrolled 24 charts

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Psoriasis, Plaque, Amyloid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡